7-107919057-A-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000108.5(DLD):​c.1422A>C​(p.Gly474Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0113 in 1,613,950 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G474G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0089 ( 6 hom., cov: 32)
Exomes 𝑓: 0.012 ( 113 hom. )

Consequence

DLD
NM_000108.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.780

Publications

3 publications found
Variant links:
Genes affected
DLD (HGNC:2898): (dihydrolipoamide dehydrogenase) This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In homodimeric form, the encoded protein functions as a dehydrogenase and is found in several multi-enzyme complexes that regulate energy metabolism. However, as a monomer, this protein can function as a protease. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
DLD Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • pyruvate dehydrogenase E3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Myriad Women’s Health, G2P, Genomics England PanelApp, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 7-107919057-A-C is Benign according to our data. Variant chr7-107919057-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137101.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.78 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0089 (1356/152324) while in subpopulation NFE AF = 0.0133 (906/68032). AF 95% confidence interval is 0.0126. There are 6 homozygotes in GnomAd4. There are 658 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000108.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DLD
NM_000108.5
MANE Select
c.1422A>Cp.Gly474Gly
synonymous
Exon 13 of 14NP_000099.2A0A024R713
DLD
NM_001289751.1
c.1353A>Cp.Gly451Gly
synonymous
Exon 12 of 13NP_001276680.1P09622
DLD
NM_001289752.1
c.1278A>Cp.Gly426Gly
synonymous
Exon 12 of 13NP_001276681.1P09622-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DLD
ENST00000205402.10
TSL:1 MANE Select
c.1422A>Cp.Gly474Gly
synonymous
Exon 13 of 14ENSP00000205402.3P09622-1
DLD
ENST00000880448.1
c.1404A>Cp.Gly468Gly
synonymous
Exon 13 of 14ENSP00000550507.1
DLD
ENST00000880447.1
c.1398A>Cp.Gly466Gly
synonymous
Exon 13 of 14ENSP00000550506.1

Frequencies

GnomAD3 genomes
AF:
0.00892
AC:
1357
AN:
152206
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00244
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.00582
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0183
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0133
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.00874
AC:
2196
AN:
251288
AF XY:
0.00875
show subpopulations
Gnomad AFR exome
AF:
0.00191
Gnomad AMR exome
AF:
0.00602
Gnomad ASJ exome
AF:
0.00665
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0183
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.0114
GnomAD4 exome
AF:
0.0115
AC:
16819
AN:
1461626
Hom.:
113
Cov.:
31
AF XY:
0.0111
AC XY:
8105
AN XY:
727124
show subpopulations
African (AFR)
AF:
0.00176
AC:
59
AN:
33466
American (AMR)
AF:
0.00599
AC:
268
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00570
AC:
149
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39674
South Asian (SAS)
AF:
0.000441
AC:
38
AN:
86254
European-Finnish (FIN)
AF:
0.0182
AC:
972
AN:
53414
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5766
European-Non Finnish (NFE)
AF:
0.0133
AC:
14786
AN:
1111826
Other (OTH)
AF:
0.00898
AC:
542
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
842
1683
2525
3366
4208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00890
AC:
1356
AN:
152324
Hom.:
6
Cov.:
32
AF XY:
0.00883
AC XY:
658
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00243
AC:
101
AN:
41558
American (AMR)
AF:
0.00582
AC:
89
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.0183
AC:
194
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0133
AC:
906
AN:
68032
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
66
131
197
262
328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0117
Hom.:
14
Bravo
AF:
0.00787
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0116
EpiControl
AF:
0.0119

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Pyruvate dehydrogenase E3 deficiency (4)
-
-
3
not provided (3)
-
-
1
Leigh syndrome (1)
-
-
1
not specified (1)
-
-
1
Pyruvate dehydrogenase complex deficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
6.6
DANN
Benign
0.81
PhyloP100
0.78
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34453495; hg19: chr7-107559502; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.